Citations

1. Petri MA (2005). Systemic lupus erythematosus: Clinical aspects. In WJ Koopman, LW Moreland, eds., Arthritis and Allied Conditions: A Textbook of Rheumatology, 15th ed., vol. 2, pp.1473-1496. Philadelphia: Lippincott Williams and Wilkins.

2. Cooper GS, et al. (2002). Hormonal and reproductive risk factors for development of systemic lupus erythematosus. Arthritis and Rheumatism, 46(7): 1830-1839.

3. Petri MA, et al. (2005). Combined oral contraceptives in women with systemic lupus erythematosus. New England Journal of Medicine, 353(24): 2550-2558.

4. Schur PH (2004). Systemic lupus erythematosus. In L Goldman, D Ausiello, eds., Cecil Textbook of Medicine, 22nd ed., vol. 2, pp. 1660-1670. Philadelphia: Saunders.

5. Keyser RE, et al. (2003). Evidence for aerobic insufficiency in women with systemic lupus erythematosus. Arthritis and Rheumatism, 49(1): 16-22.

6. Lockshin MD (2005). Systemic lupus erythematosus. In DC Dale, DD Federman, eds., ACP Medicine, section 15, chap. 4. New York: KB120.

7. Hellmann DB, Stone JH (2005). Systemic lupus erythematosus section of Arthritis and musculoskeletal disorders. In LM Tierney et al., eds., Current Medical Diagnosis and Treatment, 44th ed., pp. 807-811. New York: McGraw-Hill.

8. Bruce IN, et al. (2003). Risk factors for coronary heart disease in women with systemic lupus erythematosus. Arthritis and Rheumatism, 48(11): 3159-3167.

9. Trager J, Ward M (2001). Mortality and causes of death in systemic lupus erythematosus. Current Opinion in Rheumatology, 13(5): 345-351.

10. Wofsy D (2005). Therapy of systemic lupus erythematosus. In WJ Koopman, LW Moreland, eds., Arthritis and Allied Conditions: A Textbook of Rheumatology, 15th ed., vol. 2, pp. 1561-1574. Philadelphia: Lippincott Williams and Wilkins.

11. Jessop S (2005). Drugs for discoid lupus erythematosus. Cochrane Database of Systematic Reviews (2). Oxford: Update Software.

12. Costenbader KH, et al. (2004). Cigarette smoking and the risk of systemic lupus erythematosus. Arthritis and Rheumatism, 50(3): 849-857.

13. Hahn BH, et al. (2005). Pathogenesis of systemic lupus erythematosus. In ED Harris et al., eds., Kelley's Textbook of Rheumatology, 7th ed., vol. 2, pp. 1174-1200. Philadelphia: Elsevier Saunders.

14. Ghaussy NO, et al. (2003). Cigarette smoking and disease activity in systemic lupus erythematosus. Journal of Rheumatology, 30(6): 1215-1221.

15. Pope J, et al. (2003). Frequency of adverse drug reactions in patients with systemic lupus erythematosus. Journal of Rheumatology, 30(3): 480-484.

16. Hahn BH (2005). Management of systemic lupus erythematosus. In ED Harris et al., eds., Kelley's Textbook of Rheumatology, 7th ed., vol. 2, pp. 1225-1247. Philadelphia: Elsevier Saunders.

17. Wallace DJ (2002). Management of lupus erythematosus: Recent insights. Current Opinion in Rheumatology, 14(3): 212-219.

18. Petri MA, et al. (2004). Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. Arthritis and Rheumatism, 50(9): 2858-2868.

19. Petri M (2001). Systemic lupus erythematosus (including pregnancy and antiphospholipid antibody syndrome). In MH Weisman et al., eds., Treatment of the Rheumatic Diseases: Companion to Kelley's Textbook of Rheumatology, 2nd ed., pp. 274-288. Philadelphia: W.B. Saunders.

Other Works Consulted

• McMurray RW, May W (2003). Sex hormones and systemic lupus erythematosus: Review and meta-analysis. Arthritis and Rheumatism, 48(8): 2100-2110.